The Effect of Filaggrin Mutations on Dermal Penetration of Diisocyanates

聚丝蛋白突变对二异氰酸酯真皮渗透的影响

基本信息

项目摘要

ABSTRACT A significant portion of workers in the US could be at risk for an increase in exposure to industrial chemicals via a heritable defect resulting in a compromised epidermal barrier. The primary barrier of the skin is the epidermis, which consists of layers of differentiated keratinocytes forming a cornified structure (stratum corneum, SC). The continuity of the SC is dependent upon an integrated matrix of lipids and structural proteins, including filaggrin, that form a barrier against the external environment. The genetic determinants of barrier integrity are poorly understood. Human genetic studies suggest that the complete or partial loss of filaggrin expression results in decreased barrier function and enhanced penetration of chemicals through the skin. The importance of filaggrin to epidermal differentiation and barrier function has been made evident with the strong association of loss of function (LOF) mutations in the filaggrin gene (FLG) with the chronic human skin diseases, ichthyosis vulgaris and atopic eczema. These diseases are characterized by dry skin and a predisposition to asthma. The severity and penetrance of these heritable skin diseases are correlated with the number of FLG-mutant (LOF) alleles that may be altered by other modifier genes. We have shown that skin exposure to diisocyanates, a known respiratory sensitizer, may significantly contribute to systemic exposure. We hypothesize that partial loss (haploinsufficiency) of filaggrin content in the skin will impair barrier function resulting in increased diisocyanate penetration, dose, and toxicity. We propose to test our hypothesis by using in vitro three-dimensional (3D) human organotypic skin tissues with and without compromised barrier function. The dose-related difference in permeability and cellular toxicity to a model contact and respiratory sensitizer, 1,6-hexamethylene diisocyanate, will be measured in normal and barrier compromised human skin reconstructs. The use of a barrier-compromised human skin reconstruct model will fulfill an important need for biologically relevant methods to characterize chemical penetrance into the epidermis, to investigate the contribution of increased skin exposure to skin and systemic toxicity, and to identify individuals (susceptible subpopulation) at increased risk for adverse health effects, including sensitization, allergy, and asthma. The proposed research represents a cutting-edge exposure model for testing diisocyanate toxicity to human skin. Validation of this model test system can provide a more appropriate tool than is currently available using 2D in vitro and animal models to investigate the role of skin exposure to a chemical respiratory sensitization. As such, the scope of the research proposed is consistent with and amplifies NIOSH goals and mission to protect worker health. We have an opportunity to contribute to the NIOSH Research to Practice initiative by providing new knowledge and tools to identify potential susceptible subpopulations and, thus, strategies for intervention and control as well as to provide critical data to set exposure limits by taking into account individual variation that alter exposure classification.
摘要 美国很大一部分工人可能面临通过以下方式接触工业化学品增加的风险 导致表皮屏障受损的遗传缺陷。皮肤的主要屏障是 表皮,其由形成皮质结构(层)的分化的角质形成细胞层组成 cornum,SC)。SC的连续性取决于脂质和结构蛋白的整合基质, 包括丝聚蛋白,其形成对外部环境的屏障。屏障的遗传决定因素 对完整性了解甚少。人类遗传学研究表明丝聚蛋白的完全或部分缺失 表达导致屏障功能降低和化学物质通过皮肤的渗透增强。的 丝聚蛋白对表皮分化和屏障功能的重要性已经变得明显, 聚丝蛋白基因(FLG)中的功能丧失(LOF)突变与慢性人类皮肤病的关联 疾病,寻常鱼鳞病和特应性湿疹。这些疾病的特点是皮肤干燥, 易患哮喘这些遗传性皮肤病的严重程度和发病率与 FLG突变体(LOF)等位基因的数量可能会被其他修饰基因改变。我们已经证明皮肤 暴露于二异氰酸酯(一种已知的呼吸道致敏物)可能会显著促进全身暴露。 我们假设皮肤中聚丝蛋白含量的部分损失(单倍不足)将损害屏障功能 导致增加的二异氰酸酯渗透、剂量和毒性。我们建议用以下方法来检验我们的假设: 具有和不具有受损屏障功能的体外三维(3D)人器官型皮肤组织。 模型接触和呼吸致敏物的渗透性和细胞毒性的剂量相关差异, 将在正常和屏障受损的人类皮肤中测量1,6-二异氰酸酯 重建。使用屏障受损的人类皮肤重建模型将满足以下重要需求: 生物学相关的方法来表征化学渗透到表皮,调查 皮肤暴露增加对皮肤和全身毒性的贡献,并确定个体(易感 亚群)的不良健康影响的风险增加,包括致敏、过敏和哮喘。的 拟议的研究代表了测试二异氰酸酯对人体皮肤毒性的最先进的暴露模型。 该模型测试系统的验证可以提供比目前使用2D的更合适的工具, 体外和动物模型,以研究皮肤暴露于化学呼吸致敏的作用。作为 因此,所建议的研究范围与NIOSH的目标和保护的使命是一致的,并扩大了NIOSH的目标和保护的使命 工人健康。我们有机会为NIOSH研究实践计划做出贡献, 新的知识和工具,以确定潜在的易感亚群,从而制定干预战略 并提供关键数据,以通过考虑个体差异来设定接触限值 改变暴露分类

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LEENA A NYLANDER-FRENCH其他文献

LEENA A NYLANDER-FRENCH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LEENA A NYLANDER-FRENCH', 18)}}的其他基金

North Carolina Occupational Safety and Health Education and Research Centers
北卡罗来纳州职业安全与健康教育和研究中心
  • 批准号:
    10557681
  • 财政年份:
    2022
  • 资助金额:
    $ 20.73万
  • 项目类别:
North Carolina Occupational Safety and Health Education and Research Centers
北卡罗来纳州职业安全与健康教育和研究中心
  • 批准号:
    10895262
  • 财政年份:
    2022
  • 资助金额:
    $ 20.73万
  • 项目类别:
North Carolina Occupational Safety and Health Education and Research Centers
北卡罗来纳州职业安全与健康教育和研究中心
  • 批准号:
    10693988
  • 财政年份:
    2022
  • 资助金额:
    $ 20.73万
  • 项目类别:
Population-based Genetic Model for Diisocyanate-induced Asthma
二异氰酸酯诱发哮喘的基于群体的遗传模型
  • 批准号:
    9791313
  • 财政年份:
    2018
  • 资助金额:
    $ 20.73万
  • 项目类别:
North Carolina Occupational Safety and Health Education and Research Center
北卡罗来纳州职业安全与健康教育研究中心
  • 批准号:
    10268946
  • 财政年份:
    2017
  • 资助金额:
    $ 20.73万
  • 项目类别:
North Carolina Occupational Safety and Health Education and Research Center
北卡罗来纳州职业安全与健康教育研究中心
  • 批准号:
    10247439
  • 财政年份:
    2017
  • 资助金额:
    $ 20.73万
  • 项目类别:
The Effect of Filaggrin Mutations on Dermal Penetration of Diisocyanates
聚丝蛋白突变对二异氰酸酯真皮渗透的影响
  • 批准号:
    8931791
  • 财政年份:
    2014
  • 资助金额:
    $ 20.73万
  • 项目类别:
Quantifying Determinants of Spray Painters' Isocyanurate Exposure
量化喷漆工异氰脲酸酯暴露的决定因素
  • 批准号:
    8695659
  • 财政年份:
    2014
  • 资助金额:
    $ 20.73万
  • 项目类别:
Influence of Genetic Markers on Exposure Assessment Models
遗传标记对暴露评估模型的影响
  • 批准号:
    8301325
  • 财政年份:
    2012
  • 资助金额:
    $ 20.73万
  • 项目类别:
Comparative Toxico-Genomics and Individual Differences in Response to Dermal PAH
比较毒理学基因组学和对皮肤 PAH 反应的个体差异
  • 批准号:
    7067251
  • 财政年份:
    2006
  • 资助金额:
    $ 20.73万
  • 项目类别:

相似国自然基金

CD100-PlexinB2-Filaggrin轴对皮肤屏障功能的调控及在特应性皮炎中的作用和机制研究
  • 批准号:
    2024Y9167
  • 批准年份:
    2024
  • 资助金额:
    25.0 万元
  • 项目类别:
    省市级项目

相似海外基金

Investigation of Filaggrin Gene Mutations among Latinx patients with Atopic Dermatitis
拉丁裔特应性皮炎患者丝聚蛋白基因突变的调查
  • 批准号:
    10740811
  • 财政年份:
    2023
  • 资助金额:
    $ 20.73万
  • 项目类别:
Decontructing the Atopic March - The Role of Filaggrin Mutations in Allergic Rhinitis
解构特应性游行——丝聚蛋白突变在过敏性鼻炎中的作用
  • 批准号:
    349914
  • 财政年份:
    2015
  • 资助金额:
    $ 20.73万
  • 项目类别:
    Studentship Programs
The Effect of Filaggrin Mutations on Dermal Penetration of Diisocyanates
聚丝蛋白突变对二异氰酸酯真皮渗透的影响
  • 批准号:
    8931791
  • 财政年份:
    2014
  • 资助金额:
    $ 20.73万
  • 项目类别:
A population-based family study of filaggrin mutations and allergic disease risk in Australia
澳大利亚一项基于人群的丝聚蛋白突变和过敏性疾病风险的家庭研究
  • 批准号:
    nhmrc : 628513
  • 财政年份:
    2010
  • 资助金额:
    $ 20.73万
  • 项目类别:
    NHMRC Project Grants
Filaggrin and epidermal differentiation complex gene mutations in peanut allergy
花生过敏中的聚丝蛋白和表皮分化复合体基因突变
  • 批准号:
    204475
  • 财政年份:
    2010
  • 资助金额:
    $ 20.73万
  • 项目类别:
    Fellowship Programs
Filaggrin and epidermal differentiation complex gene mutations in peanut allergy
花生过敏中的聚丝蛋白和表皮分化复合体基因突变
  • 批准号:
    206440
  • 财政年份:
    2010
  • 资助金额:
    $ 20.73万
  • 项目类别:
    Fellowship Programs
Filaggrin Mutations and the Prognosis of Atopic Dermatitis
聚丝蛋白突变与特应性皮炎的预后
  • 批准号:
    8321208
  • 财政年份:
    2009
  • 资助金额:
    $ 20.73万
  • 项目类别:
Filaggrin Mutations and the Prognosis of Atopic Dermatitis
聚丝蛋白突变与特应性皮炎的预后
  • 批准号:
    7808038
  • 财政年份:
    2009
  • 资助金额:
    $ 20.73万
  • 项目类别:
Filaggrin Mutations and the Prognosis of Atopic Dermatitis
聚丝蛋白突变与特应性皮炎的预后
  • 批准号:
    8242639
  • 财政年份:
    2009
  • 资助金额:
    $ 20.73万
  • 项目类别:
Filaggrin Mutations and the Prognosis of Atopic Dermatitis
聚丝蛋白突变与特应性皮炎的预后
  • 批准号:
    8040004
  • 财政年份:
    2009
  • 资助金额:
    $ 20.73万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了